UniProt A0FGR8
A0FGR8
A0FGR8 (UniProt A0FGR8): 6 experimental structures and 1 predicted model on GenesisL1. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- A0FGR8
- Experimental structures
- 6
- Predicted models
- 1
Structures
7 records of A0FGR8 in the MolNFT archive: 6 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 4NPJ | Extended-Synaptotagmin 2, C2A- and C2B-domains | x-ray diffraction | A, B | — | — |
| 4NPJ | Extended-synaptotagmin 2, C2A- and C2B-domains | x-ray diffraction | A, B | — | — |
| 4NPK | Extended-Synaptotagmin 2, C2A- and C2B-domains, calcium bound | x-ray diffraction | A | — | — |
| 4NPK | Extended-synaptotagmin 2, C2A- and C2B-domains, calcium bound | x-ray diffraction | A | — | — |
| 4P42 | Extended-Synaptotagmin 2, SMP - C2A - C2B Domains | x-ray diffraction | A, B | — | — |
| 4P42 | Extended-synaptotagmin 2, smp - C2A - C2B domains | x-ray diffraction | A, B | — | — |
| A0FGR8 | AlphaFold monomer V2.0 prediction for extended synaptotagmin-2 (A0FGR8) | predicted | A | — | — |
Experiment against prediction
- 4NPK chain A against the predicted model A0FGR8: TM-score 0.98, RMSD 1.17 Å
- 4NPK chain A against the predicted model A0FGR8: TM-score 0.98, RMSD 1.17 Å
- 4P42 chain B against the predicted model A0FGR8: TM-score 0.94, RMSD 1.84 Å
- 4P42 chain B against the predicted model A0FGR8: TM-score 0.94, RMSD 1.84 Å
- 4NPJ chain B against the predicted model A0FGR8: TM-score 0.93, RMSD 1.43 Å
- 4NPJ chain B against the predicted model A0FGR8: TM-score 0.93, RMSD 1.43 Å
- 4NPJ chain A against the predicted model A0FGR8: TM-score 0.91, RMSD 1.78 Å
- 4NPJ chain A against the predicted model A0FGR8: TM-score 0.91, RMSD 1.78 Å
- 4P42 chain A against the predicted model A0FGR8: TM-score 0.60, RMSD 3.14 Å
- 4P42 chain A against the predicted model A0FGR8: TM-score 0.60, RMSD 3.14 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.